サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1420964

創薬インフォマティクス市場：世界の業界分析、規模、シェア、成長、動向、予測、2023年～2031年

Drug Discovery Informatics Market (Product: Discovery Informatics and Development Informatics; and Mode: In-house Informatics and Outsourced Informatics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2031
出版日: | 発行: Transparency Market Research | ページ情報: 英文 229 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.70円
創薬インフォマティクス市場：世界の業界分析、規模、シェア、成長、動向、予測、2023年～2031年
出版日: 2023年12月29日
発行: Transparency Market Research
ページ情報: 英文 229 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

創薬インフォマティクス市場- レポートの範囲

世界の創薬インフォマティクス学市場に関するTMRのレポートは、過去と現在の成長動向、および2023年から2031年の予測期間中に市場の指標の貴重な洞察を得る機会を研究しています。このレポートは、世界の創薬インフォマティクス学市場の収益を提供し、2023年を基準年、2031年を予測年とみなして、2017年から2031年の期間の市場を分析します。このレポートは、2023年から2031年までの世界の創薬インフォマティクス市場の複合年間成長率（CAGR %）も提供します。

このレポートは広範な調査を経て作成されました。1次調査では、調査活動の大部分が行われ、アナリストが主要なオピニオンリーダー、業界リーダー、オピニオンメーカーにインタビューを実施しました。2次調査には、創薬インフォマティクス市場を理解するために、主要企業の製品文献、年次報告書、プレスリリース、および関連文書の参照が含まれます。

市場スナップショット
2023年の市場価値 27億米ドル
2031年の市場価値 68億米ドル
CAGR 10.9%

このレポートは、世界の創薬インフォマティクス市場の競合情勢を詳しく掘り下げています。世界の創薬インフォマティクス市場で活動する主要企業が特定され、それぞれの企業がさまざまな属性の観点からプロファイルされています。会社概要、財務状況、最近の動向、 SWOTは、このレポートで紹介されている世界の創薬インフォマティクス学市場のプレーヤーの属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界市場の分析と予測、2023～2031年

第5章 重要な洞察

  • パイプライン分析
  • 主要製品/ブランド分析
  • 主な合併と買収
  • COVID-19のパンデミックが業界に与える影響

第6章 世界市場の分析と予測：製品別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：製品別、2017-2031
    • 発見インフォマティクス
    • 開発インフォマティクス
  • 市場の魅力：製品別

第7章 世界市場の分析と予測：モード別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：モード別、2017-2031
    • 社内
    • アウトソーシング
  • 市場の魅力：モード別

第8章 世界市場の分析と予測：機能別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：機能別、2017-2031
    • シーケンシング・対象データ分析
    • ドッキング
    • リード生成インフォマティクス
    • 同定・検証インフォマティクス
    • 分子モデリング
    • その他
  • 市場の魅力：機能別

第9章 世界市場の分析と予測：エンドユーザー別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：エンドユーザー別、2017-2031
    • 製薬企業・バイオテクノロジー企業
    • CRO
    • その他
  • 市場の魅力：エンドユーザー別

第10章 世界市場の分析と予測：地域別

  • 主な調査結果
  • 市場金額予測：地域別、2017-2031
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力：地域別

第11章 北米市場の分析と予測

第12章 欧州市場の分析と予測

第13章 アジア太平洋市場の分析と予測

第14章 ラテンアメリカ市場の分析と予測

第15章 中東およびアフリカ市場の分析と予測

第16章 競合情勢

  • 市場プレーヤー-競合マトリックス（企業の階層および規模別）
  • 市場シェア分析：企業別（2022年）
  • 企業プロファイル
    • Charles River Laboratories International, Inc.
    • Thermo Fisher Scientific
    • PerkinElmer Inc.
    • Biogen Inc.
    • Boehringer Ingelheim GmbH
    • Insilico Medicine, Inc.
    • International Business Machines Corporation
    • Schrodinger, LLC
    • Curia Global, Inc.
    • Certara, USA
図表

List of Tables

  • Table 01: Global Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 02: Global Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Mode, 2017-2031
  • Table 03: Global Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Function, 2017-2031
  • Table 04: Global Drug Discovery Informatics Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 05: Global Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 06: North America Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Country, 2017-2031
  • Table 07: North America Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 08: North America Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Mode, 2017-2031
  • Table 09: North America Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Function, 2017-2031
  • Table 10: North America Drug Discovery Informatics Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 11: Europe Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 12: Europe Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 13: Europe Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Mode, 2017-2031
  • Table 14: Europe Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Function, 2017-2031
  • Table 15: Europe Drug Discovery Informatics Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 16: Asia Pacific Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 17: Asia Pacific Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 18: Asia Pacific Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Mode, 2017-2031
  • Table 19: Asia Pacific Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Function, 2017-2031
  • Table 20: Asia Pacific Drug Discovery Informatics Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 21: Latin America Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Latin America Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 23: Latin America Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Mode, 2017-2031
  • Table 24: Latin America Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Function, 2017-2031
  • Table 25: Latin America Drug Discovery Informatics Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 26: Middle East & Africa Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 27: Middle East & Africa Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 28: Middle East & Africa Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Mode, 2017-2031
  • Table 29: Middle East & Africa Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Function, 2017-2031
  • Table 30: Middle East & Africa Drug Discovery Informatics Market Size (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Drug Discovery Informatics Market Size (US$ Mn) and Distribution (%), by Region, 2022 and 2031
  • Figure 02: Global Drug Discovery Informatics Market Revenue (US$ Mn), by Product, 2022
  • Figure 03: Global Drug Discovery Informatics Market Value Share, by Product, 2022
  • Figure 04: Global Drug Discovery Informatics Market Revenue (US$ Mn), by Mode, 2022
  • Figure 05: Global Drug Discovery Informatics Market Value Share, by Mode, 2022
  • Figure 06: Global Drug Discovery Informatics Market Revenue (US$ Mn), by Function, 2022
  • Figure 07: Global Drug Discovery Informatics Market Value Share, by Function, 2022
  • Figure 08: Global Drug Discovery Informatics Market Value Share, by End-user, 2022
  • Figure 09: Global Drug Discovery Informatics Market Value Share, by End-user, 2022
  • Figure 10: Global Drug Discovery Informatics Market Value Share, by Region, 2022
  • Figure 11: Global Drug Discovery Informatics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 12: Global Drug Discovery Informatics Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 13: Global Drug Discovery Informatics Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 14: Global Drug Discovery Informatics Market Value Share Analysis, by Mode, 2022 and 2031
  • Figure 15: Global Drug Discovery Informatics Market Attractiveness Analysis, by Mode, 2023-2031
  • Figure 16: Global Drug Discovery Informatics Market Value Share Analysis, by Function, 2022 and 2031
  • Figure 17: Global Drug Discovery Informatics Market Attractiveness Analysis, by Function, 2023-2031
  • Figure 18: Global Drug Discovery Informatics Market Revenue (US$ Mn), by End-user, 2022
  • Figure 19: Global Drug Discovery Informatics Market Value Share, by End-user, 2022
  • Figure 20: Global Drug Discovery Informatics Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 21: Global Drug Discovery Informatics Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 22: North America Drug Discovery Informatics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 23: North America Drug Discovery Informatics Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 24: North America Drug Discovery Informatics Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 25: North America Drug Discovery Informatics Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 26: North America Drug Discovery Informatics Market Value Share Analysis, by Mode, 2022 and 2031
  • Figure 27: North America Drug Discovery Informatics Market Value Share Analysis, by Function, 2022 and 2031
  • Figure 28: North America Drug Discovery Informatics Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 29: North America Drug Discovery Informatics Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 30: North America Drug Discovery Informatics Market Attractiveness Analysis, by Mode, 2023-2031
  • Figure 31: North America Drug Discovery Informatics Market Attractiveness Analysis, by Function, 2023-2031
  • Figure 32: North America Drug Discovery Informatics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 33: Europe Drug Discovery Informatics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 34: Europe Drug Discovery Informatics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 35: Europe Drug Discovery Informatics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 36: Europe Drug Discovery Informatics Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 37: Europe Drug Discovery Informatics Market Value Share Analysis, by Mode, 2022 and 2031
  • Figure 38: Europe Drug Discovery Informatics Market Value Share Analysis, by Function, 2022 and 2031
  • Figure 39: Europe Drug Discovery Informatics Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 40: Europe Drug Discovery Informatics Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 41: Europe Drug Discovery Informatics Market Attractiveness Analysis, by Mode, 2023-2031
  • Figure 42: Europe Drug Discovery Informatics Market Attractiveness Analysis, by Function, 2023-2031
  • Figure 43: Europe Drug Discovery Informatics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 44: Asia Pacific Drug Discovery Informatics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023-2031
  • Figure 45: Asia Pacific Drug Discovery Informatics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 46: Asia Pacific Drug Discovery Informatics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 47: Asia Pacific Drug Discovery Informatics Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 48: Asia Pacific Drug Discovery Informatics Market Value Share Analysis, by Mode, 2022 and 2031
  • Figure 49: Asia Pacific Drug Discovery Informatics Market Value Share Analysis, by Function, 2022 and 2031
  • Figure 50: Asia Pacific Drug Discovery Informatics Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 51: Asia Pacific Drug Discovery Informatics Market Attractiveness Analysis, by Product, 2017-2031
  • Figure 52: Asia Pacific Drug Discovery Informatics Market Attractiveness Analysis, by Mode, 2023-2031
  • Figure 53: Asia Pacific Drug Discovery Informatics Market Attractiveness Analysis, by Function, 2023-2031
  • Figure 54: Asia Pacific Drug Discovery Informatics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 55: Latin America Drug Discovery Informatics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 56: Latin America Drug Discovery Informatics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 57: Latin America Drug Discovery Informatics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 58: Latin America Drug Discovery Informatics Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 59: Latin America Drug Discovery Informatics Market Value Share Analysis, by Mode, 2022 and 2031
  • Figure 60: Latin America Drug Discovery Informatics Market Value Share Analysis, by Function, 2022 and 2031
  • Figure 61: Latin America Drug Discovery Informatics Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 62: Latin America Drug Discovery Informatics Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 63: Latin America Drug Discovery Informatics Market Attractiveness Analysis, by Mode, 2023-2031
  • Figure 64: Latin America Drug Discovery Informatics Market Attractiveness Analysis, by Function, 2023-2031
  • Figure 65: Latin America Drug Discovery Informatics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 66: Middle East & Africa Drug Discovery Informatics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 67: Middle East & Africa Drug Discovery Informatics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 68: Middle East & Africa Drug Discovery Informatics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 69: Middle East & Africa Drug Discovery Informatics Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 70: Middle East & Africa Drug Discovery Informatics Market Value Share Analysis, by Mode, 2022 and 2031
  • Figure 71: Middle East & Africa Drug Discovery Informatics Market Value Share Analysis, by Function, 2022 and 2031
  • Figure 72: Middle East & Africa Drug Discovery Informatics Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 73: Middle East & Africa Drug Discovery Informatics Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 74: Middle East & Africa Drug Discovery Informatics Market Attractiveness Analysis, by Mode, 2023-2031
  • Figure 75: Middle East & Africa Drug Discovery Informatics Market Attractiveness Analysis, by Function, 2023-2031
  • Figure 76: Middle East & Africa Drug Discovery Informatics Market Attractiveness Analysis, by End-user, 2023-2031
目次
Product Code: TMRGL33713

Drug Discovery Informatics Market - Scope of Report

TMR's report on the global drug discovery informatics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global drug discovery informatics market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global drug discovery informatics market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the drug discovery informatics market.

Market Snapshot
Market Value in 2023US$ 2.7 Bn
Market Value in 2031US$ 6.8 Bn
CAGR10.9%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global drug discovery informatics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global drug discovery informatics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global drug discovery informatics market.

The report delves into the competitive landscape of the global drug discovery informatics market. Key players operating in the global drug discovery informatics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global drug discovery informatics market profiled in this report.

Key Questions Answered in Global drug discovery informatics Market Report:

  • What is the sales/revenue generated by drug discovery informatics across all regions during the forecast period?
  • What are the opportunities in the global drug discovery informatics market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Drug Discovery Informatics Market - Research Objectives and Research Approach

The comprehensive report on the global drug discovery informatics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global drug discovery informatics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global drug discovery informatics market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Drug Discovery Informatics Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Drug Discovery Informatics Market Analysis and Forecast, 2023-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Drug Discovery Informatics Market Analysis and Forecast, by Product

  • 6.1. Introduction and Definitions
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product, 2017-2031
    • 6.3.1. Discovery Informatics
    • 6.3.2. Development Informatics
  • 6.4. Market Attractiveness, by Product

7. Global Drug Discovery Informatics Market Analysis and Forecast, by Mode

  • 7.1. Introduction and Definitions
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Mode, 2017-2031
    • 7.3.1. In-house Informatics
    • 7.3.2. Outsourced Informatics
  • 7.4. Market Attractiveness, by Mode

8. Global Drug Discovery Informatics Market Analysis and Forecast, by Function

  • 8.1. Introduction and Definitions
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Function, 2017-2031
    • 8.3.1. Sequencing and Target Data Analysis
    • 8.3.2. Docking
    • 8.3.3. Lead Generation Informatics
    • 8.3.4. Identification and Validation Informatics
    • 8.3.5. Molecular Modeling
    • 8.3.6. Others
  • 8.4. Market Attractiveness, by Function

9. Global Drug Discovery Informatics Market Analysis and Forecast, by End-user

  • 9.1. Introduction and Definitions
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by End-user, 2017-2031
    • 9.3.1. Pharmaceutical and Biotechnology Companies
    • 9.3.2. Contract Research Organizations
    • 9.3.3. Others
  • 9.4. Market Attractiveness, by End-user

10. Global Drug Discovery Informatics Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2017-2031
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness, by Region

11. North America Drug Discovery Informatics Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product, 2017-2031
    • 11.2.1. Discovery Informatics
    • 11.2.2. Development Informatics
  • 11.3. Market Attractiveness, by Product
  • 11.4. Market Value Forecast, by Mode, 2017-2031
    • 11.4.1. In-house Informatics
    • 11.4.2. Outsourced Informatics
  • 11.5. Market Attractiveness, by Mode
  • 11.6. Market Value Forecast, by Function, 2017-2031
    • 11.6.1. Sequencing and Target Data Analysis
    • 11.6.2. Docking
    • 11.6.3. Lead Generation Informatics
    • 11.6.4. Identification and Validation Informatics
    • 11.6.5. Molecular Modeling
    • 11.6.6. Others
  • 11.7. Market Attractiveness, by Function
  • 11.8. Market Value Forecast, by End-user
    • 11.8.1. Pharmaceutical and Biotechnology Companies
    • 11.8.2. Contract Research Organizations
    • 11.8.3. Others
  • 11.9. Market Attractiveness, by End-user
  • 11.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.10.1. U.S.
    • 11.10.2. Canada
  • 11.11. Market Attractiveness Analysis
    • 11.11.1. By Product
    • 11.11.2. By Mode
    • 11.11.3. By Function
    • 11.11.4. By End-user
    • 11.11.5. By Country

12. Europe Drug Discovery Informatics Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product, 2017-2031
    • 12.2.1. Discovery Informatics
    • 12.2.2. Development Informatics
  • 12.3. Market Attractiveness, by Product
  • 12.4. Market Value Forecast, by Mode, 2017-2031
    • 12.4.1. In-house Informatics
    • 12.4.2. Outsourced Informatics
  • 12.5. Market Attractiveness, by Mode
  • 12.6. Market Value Forecast, by Function, 2017-2031
    • 12.6.1. Sequencing and Target Data Analysis
    • 12.6.2. Docking
    • 12.6.3. Lead Generation Informatics
    • 12.6.4. Identification and Validation Informatics
    • 12.6.5. Molecular Modeling
    • 12.6.6. Others
  • 12.7. Market Attractiveness, by Function
  • 12.8. Market Value Forecast, by End-user, 2017-2031
    • 12.8.1. Pharmaceutical and Biotechnology Companies
    • 12.8.2. Contract Research Organizations
    • 12.8.3. Others
  • 12.9. Market Attractiveness, by End-user
  • 12.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.10.1. Germany
    • 12.10.2. U.K.
    • 12.10.3. France
    • 12.10.4. Italy
    • 12.10.5. Spain
    • 12.10.6. Rest of Europe
  • 12.11. Market Attractiveness Analysis
    • 12.11.1. By Product
    • 12.11.2. By Mode
    • 12.11.3. By Function
    • 12.11.4. By End-user
    • 12.11.5. By Country/Sub-region

13. Asia Pacific Drug Discovery Informatics Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product, 2017-2031
    • 13.2.1. Discovery Informatics
    • 13.2.2. Development Informatics
  • 13.3. Market Attractiveness, by Product
  • 13.4. Market Value Forecast, by Mode, 2017-2031
    • 13.4.1. In-house Informatics
    • 13.4.2. Outsourced Informatics
  • 13.5. Market Attractiveness, by Mode
  • 13.6. Market Value Forecast, by Function, 2017-2031
    • 13.6.1. Sequencing and Target Data Analysis
    • 13.6.2. Docking
    • 13.6.3. Lead Generation Informatics
    • 13.6.4. Identification and Validation Informatics
    • 13.6.5. Molecular Modeling
    • 13.6.6. Others
  • 13.7. Market Attractiveness, by Function
  • 13.8. Market Value Forecast, by End-user, 2017-2031
    • 13.8.1. Pharmaceutical and Biotechnology Companies
    • 13.8.2. Contract Research Organizations
    • 13.8.3. Others
  • 13.9. Market Attractiveness, by End-user
  • 13.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.10.1. China
    • 13.10.2. Japan
    • 13.10.3. India
    • 13.10.4. Australia & New Zealand
    • 13.10.5. Rest of Asia Pacific
  • 13.11. Market Attractiveness Analysis
    • 13.11.1. By Product
    • 13.11.2. By Mode
    • 13.11.3. By Function
    • 13.11.4. By End-user
    • 13.11.5. By Country/Sub-region

14. Latin America Drug Discovery Informatics Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product, 2017-2031
    • 14.2.1. Discovery Informatics
    • 14.2.2. Development Informatics
  • 14.3. Market Attractiveness, by Product
  • 14.4. Market Value Forecast, by Mode, 2017-2031
    • 14.4.1. In-house Informatics
    • 14.4.2. Outsourced Informatics
  • 14.5. Market Attractiveness, by Mode
  • 14.6. Market Value Forecast, by Function, 2017-2031
    • 14.6.1. Sequencing and Target Data Analysis
    • 14.6.2. Docking
    • 14.6.3. Lead Generation Informatics
    • 14.6.4. Identification and Validation Informatics
    • 14.6.5. Molecular Modeling
    • 14.6.6. Others
  • 14.7. Market Attractiveness, by Function
  • 14.8. Market Value Forecast, by End-user, 2017-2031
    • 14.8.1. Pharmaceutical and Biotechnology Companies
    • 14.8.2. Contract Research Organizations
    • 14.8.3. Others
  • 14.9. Market Attractiveness, by End-user
  • 14.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.10.1. Brazil
    • 14.10.2. Mexico
    • 14.10.3. Rest of Latin America
  • 14.11. Market Attractiveness Analysis
    • 14.11.1. By Product
    • 14.11.2. By Mode
    • 14.11.3. By Function
    • 14.11.4. By End-user
    • 14.11.5. By Country/Sub-region

15. Middle East & Africa Drug Discovery Informatics Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Product, 2017-2031
    • 15.2.1. Discovery Informatics
    • 15.2.2. Development Informatics
  • 15.3. Market Attractiveness, by Product
  • 15.4. Market Value Forecast, by Mode, 2017-2031
    • 15.4.1. In-house Informatics
    • 15.4.2. Outsourced Informatics
  • 15.5. Market Attractiveness, by Mode
  • 15.6. Market Value Forecast, by Function, 2017-2031
    • 15.6.1. Sequencing and Target Data Analysis
    • 15.6.2. Docking
    • 15.6.3. Lead Generation Informatics
    • 15.6.4. Identification and Validation Informatics
    • 15.6.5. Molecular Modeling
    • 15.6.6. Others
  • 15.7. Market Attractiveness, by Function
  • 15.8. Market Value Forecast, by End-user, 2017-2031
    • 15.8.1. Pharmaceutical and Biotechnology Companies
    • 15.8.2. Contract Research Organizations
    • 15.8.3. Others
  • 15.9. Market Attractiveness, by End-user
  • 15.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.10.1. GCC Countries
    • 15.10.2. South Africa
    • 15.10.3. Rest of Middle East & Africa
  • 15.11. Market Attractiveness Analysis
    • 15.11.1. By Product
    • 15.11.2. By Mode
    • 15.11.3. By Function
    • 15.11.4. By End-user
    • 15.11.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 16.2. Market Share Analysis, by Company (2022)
  • 16.3. Company Profiles
    • 16.3.1. Charles River Laboratories International, Inc.
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Thermo Fisher Scientific
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. PerkinElmer Inc.
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Biogen Inc.
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Boehringer Ingelheim GmbH
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. Insilico Medicine, Inc.
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. International Business Machines Corporation
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Schrodinger, LLC
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. Curia Global, Inc.
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. Certara, USA
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Product Portfolio
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview